🍪 CompoundTalk uses cookies to improve your experience, analyze traffic, and personalize content. By continuing to use this site, you agree to our Cookie Policy.
Evidence-based GLP-1 & peptide discussion since 2023
ForumsPublic SquareRetatrutide anticipation thread — what are your questions for Phase 3? Page 4

Retatrutide anticipation thread — what are your questions for Phase 3?

rick_sfbay Mon, Mar 23, 2026 at 11:14 PM 32 replies 903 viewsPage 4 of 7
ingrid_STO
Member
345
1,456
Jul 2024
Stockholm, SE
Mar 30, 2026 at 2:07 AM#16

Adding the clinical framing, because it changes how the question reads. Most of what circulates confidently in this community traces back to one summary of one study, and the qualifier was dropped somewhere in the third retelling.

25 23VendorMark, COA_Karl, MikeFit_NJ and 22 others
Reply Quote Save Share Report
mike.trainer_LA
Senior Member
1,567
7,234
Apr 2024
Los Angeles, CA
Mar 31, 2026 at 1:39 AM#17
ingrid_STO said:
Most of what circulates confidently in this community traces back to one summary of one study, and the qualifier was dropped somewhere in the third…

Careful with the causal language. Two things moving together in a period when five things changed is not a mechanism, and stating it as one makes the thread less useful to somebody reading it later.

26 24newstart_MO, mia_MS2, LeilaHI and 23 others
Reply Quote Save Share Report
pam_columbus
Member
312
1,345
Aug 2024
Columbus, OH
Apr 1, 2026 at 1:10 AM#18
ingrid_STO said:
Most of what circulates confidently in this community traces back to one summary of one study, and the qualifier was dropped somewhere in the third…

That is right, and it stops being right at the edges. The general case is well behaved; the interesting cases in this thread are all at the boundary where the general case breaks.

Worth separating that from the trial evidence, which this thread keeps folding into the same question. They behave differently and the advice does not transfer.

27 0Dr.LipidDallas, alex_tucson, kevin_tulsa and 24 others
Reply Quote Save Share Report

PeptideMeter — Independent Peptide Analytics

Community-driven peptide testing and vendor rating platform. Transparent results. Unbiased analysis. Trusted by thousands.

View Results
PharmacoVig_BOS
Senior Member
1,567
8,901
Feb 2024
Boston, MA
Apr 2, 2026 at 12:41 AM#19
ingrid_STO said:
Most of what circulates confidently in this community traces back to one summary of one study, and the qualifier was dropped somewhere in the third…

Genuinely useful, thank you. I had the facts and not the framework.

28 1kate.chem, DataDave, Dr.GutHealth and 25 others
Reply Quote Save Share Report
Admin
Administrator
2,456
9,812
Oct 2023
Online
Apr 3, 2026 at 12:11 AM#20

Moderator note: good thread. Keeping it here rather than moving it, because the question is general enough to be useful.

50 23PeptideSynthNJ, Dr.KarenChen, Dr.NateNeph and 47 others
Reply Quote Save Share Report

Similar Threads

SELECT trial 4-year follow-up data released — sustained MACE reduction16 replies
GLP-1 receptor agonists and thyroid C-cell concerns — evidence review19 replies
Is there a ceiling effect for GLP-1-mediated weight loss?20 replies
Comparative pharmacokinetics: semaglutide vs tirzepatide vs retatrutide6 replies
My 18-month semaglutide journey — comprehensive data log20 replies
ForumsNewTrendingMembersAccount

Log In

Forgot password?
No account? Register